USD 0.51
(-57.51%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | -53.2 Million | 111.4 Million | 166.1 Million | 87.4 Million | 132 Million | 217 Million |
Net Income | -28.4 Million | 155.6 Million | 112.2 Million | 12.4 Million | 155.9 Million | -265.4 Million |
Depreciation & Amortization | 37.3 Million | 39.7 Million | 44.7 Million | 55.2 Million | 58.2 Million | 60.5 Million |
Deferred income taxes | 211.3 Million | -36.6 Million | 5.8 Million | 19.1 Million | 59.8 Million | 307.7 Million |
Stock-based compensation | 6 Million | 8.6 Million | 8.9 Million | 10.4 Million | 14.5 Million | 22.6 Million |
Change in working capital | -254.6 Million | -70.9 Million | 20.9 Million | -75.4 Million | -169.7 Million | 5.6 Million |
Other non-cash items | -24.8 Million | 15 Million | -26.4 Million | 65.7 Million | 13.3 Million | 86 Million |
Investing Cash Flow | -29.2 Million | 18.2 Million | 31.5 Million | -27 Million | -34.7 Million | -57.6 Million |
Investments in PPE | -33 Million | -35.1 Million | -27.9 Million | -61 Million | -75.4 Million | -72.3 Million |
Acquisitions | 6.8 Million | 50.9 Million | 59.1 Million | 34 Million | 40.7 Million | 14.7 Million |
Investment purchases | -4.9 Million | -53.8 Million | -14.1 Million | - | - | - |
Sales/Maturities of investments | -6.8 Million | 2.9 Million | -45 Million | - | - | - |
Other Investing Activities | 8.7 Million | 53.3 Million | 59.4 Million | 34 Million | 40.7 Million | 14.7 Million |
Financing Cash Flow | -70.7 Million | -19.2 Million | -169 Million | -85.3 Million | -79 Million | -116.6 Million |
Debt repayment | -9 Million | -757.3 Million | -552.9 Million | -1.6 Million | -1.9 Million | -2 Million |
Dividends payments | - | - | - | -74.3 Million | -137.8 Million | -139.5 Million |
Common Stock Repurchased | -76.9 Million | -25 Million | -1.6 Million | -900 Thousand | -101.7 Million | -2.5 Million |
Common Stock Issuance | - | 500 Thousand | 200 Thousand | - | 300 Thousand | 11.8 Million |
Other Financing Activities | -2.8 Million | 763.1 Million | 385.5 Million | -8.5 Million | 162.4 Million | 27.4 Million |
Accounts receivables | 14.2 Million | 1.5 Million | -13.9 Million | 9.3 Million | -33.8 Million | -33.7 Million |
Accounts payables | -79.3 Million | -13.2 Million | 46.7 Million | -28.6 Million | -43.8 Million | 44.1 Million |
Inventory | 3.8 Million | -51 Million | -8.8 Million | -1.6 Million | -25.8 Million | -18.8 Million |
Other working capital | -193.3 Million | -8.2 Million | -3.1 Million | -54.5 Million | -66.3 Million | 14 Million |
Cash at beginning of period | 273.8 Million | 150.5 Million | 126.1 Million | 151.9 Million | 147.2 Million | 93.2 Million |
Cash at end of period | 120.2 Million | 273.8 Million | 150.5 Million | 126.1 Million | 151.9 Million | 144.1 Million |
Capital Expenditure | -33 Million | -35.1 Million | -27.9 Million | -61 Million | -75.4 Million | -72.3 Million |
Effect of forex changes on cash | -4.1 Million | -10.6 Million | -4.2 Million | -900 Thousand | -13.6 Million | 8.1 Million |
Net cash flow / Change in cash | -153.6 Million | 123.3 Million | 24.4 Million | -25.8 Million | 4.7 Million | 50.9 Million |
Free Cash Flow | -86.2 Million | 76.3 Million | 138.2 Million | 26.4 Million | 56.6 Million | 144.7 Million |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -53.7 Million | -30.1 Million | -39.5 Million | -28.4 Million | -35.2 Million | -3.8 Million |
Depreciation & Amortization | - | - | - | 37.3 Million | 8.4 Million | 9.2 Million |
Deferred income taxes | - | - | - | 211.3 Million | 211.2 Million | -3.5 Million |
Stock-based compensation | 800 Thousand | 1.1 Million | 1.6 Million | 6 Million | 1.1 Million | -1 Million |
Change in working capital | 26.4 Million | -6.5 Million | -16.39 Million | -254.6 Million | 31.3 Million | -14 Million |
Other non-cash items | 42.1 Million | 29.4 Million | 37.39 Million | -24.8 Million | -199.4 Million | 1.4 Million |
Investing Cash Flow | -1.8 Million | 9.4 Million | -2.5 Million | -29.2 Million | -14.3 Million | -500 Thousand |
Investments in PPE | -2.1 Million | -3.1 Million | -3.6 Million | -33 Million | -7.1 Million | -10.3 Million |
Acquisitions | 300 Thousand | 12.5 Million | 1.1 Million | 6.8 Million | 2.7 Million | 2.9 Million |
Investment purchases | - | - | - | -4.9 Million | - | - |
Sales/Maturities of investments | - | - | - | -6.8 Million | - | - |
Other Investing Activities | 300 Thousand | 12.5 Million | 1.1 Million | 8.7 Million | -9.9 Million | 6.9 Million |
Financing Cash Flow | 900 Thousand | 3 Million | 31 Million | -70.7 Million | -6.4 Million | 8.9 Million |
Debt repayment | -900 Thousand | -3.3 Million | -32.1 Million | -9 Million | -3 Million | -8.3 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -300 Thousand | -1.1 Million | -76.9 Million | 75 Million | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1.1 Million | -300 Thousand | -1.1 Million | -2.8 Million | -3.4 Million | 600 Thousand |
Accounts receivables | - | - | - | 14.2 Million | 8.5 Million | 5 Million |
Accounts payables | - | - | - | -79.3 Million | -26.2 Million | -2.8 Million |
Inventory | - | - | - | 3.8 Million | 35.9 Million | -13.4 Million |
Other working capital | 26.4 Million | -6.5 Million | -16.39 Million | -193.3 Million | 13.1 Million | -2.8 Million |
Cash at beginning of period | 123.8 Million | 122.4 Million | 114.2 Million | 273.8 Million | 111.6 Million | 126.7 Million |
Cash at end of period | 129.4 Million | 123.8 Million | 122.4 Million | 120.2 Million | 120.2 Million | 111.6 Million |
Capital Expenditure | -2.1 Million | -3.1 Million | -3.6 Million | -33 Million | -7.1 Million | -10.3 Million |
Effect of forex changes on cash | -7.8 Million | -3.7 Million | -3.5 Million | -4.1 Million | 8.3 Million | -8.5 Million |
Net cash flow / Change in cash | 5.6 Million | 1.4 Million | 8.2 Million | -153.6 Million | 8.6 Million | -15.1 Million |
Free Cash Flow | 13.5 Million | -9.2 Million | -20.5 Million | -86.2 Million | 10.3 Million | -22 Million |
U
MALDF
CGHLY
5026
NNN1
CHEMOPH